At first event to be jointly organised by European Innovation Council and European Institute of Innovation and Technology, entrepreneurs call for EU to fill gaps in support and funding their companies need to scale up and be profitable
Relief bill has money to help researchers over the COVID-19 crisis and fill gaps in US response, such as viral genome sequencing and zoonotic disease work. But some say it is a fraction of what is needed for science to recover fully
COVID-19 has brought science to the forefront of policymaking around the world, and science advisers have become minor celebrities. Now, the public demands the experts are consulted, says Canada’s chief science adviser
EU director of public health calls for better pandemic preparedness, as health commissioner tells Science|Business conference that vaccine rollout is ‘gathering pace’
Money will fund sequencing to pick up dangerous variants and trials network to test updated vaccines. Vaccines approvals will be eased and supply contracts modified. The initiatives are a dry run for the proposed Health Emergency Preparedness and Response Authority
From setting standards for genetic newborn screening to helping pharma create a shared platform to treat thousands of rare diseases, IMI is ready to help drive the science forward.
The focus will be on post COVID-19 recovery, with leaked draft work programme indicating that in 2021 researchers can expect six calls for proposals on topics ranging from mental health to improving healthcare systems
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.